New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - amisulpride 400mg;  ;   - tablet - 400 mg - active: amisulpride 400mg     excipient: hypromellose   lactose monohydrate macrogol stearate 2000 magnesium stearate microcrystalline cellulose powdered cellulose sodium starch glycolate titanium dioxide - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - alemtuzumab 10 mg/ml - concentrate for infusion - 10 mg/ml - active: alemtuzumab 10 mg/ml excipient: dibasic sodium phosphate disodium edetate dihydrate monobasic potassium phosphate polysorbate 80 potassium chloride sodium chloride - treatment of relapsing forms of multiple sclerosis (ms) for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - milrinone 1.43 mg/ml (as lactate. equivalent to 1mg/ml milrinone) - solution for injection - 1 mg/ml - active: milrinone 1.43 mg/ml (as lactate. equivalent to 1mg/ml milrinone) excipient: glucose monohydrate lactic acid sodium hydroxide water for injection - primacor injection is indicated for the short term intravenous therapy of severe congestive heart failure. the majority of experience with intravenous primacor has been in patients receiving digoxin and diuretics. primacor is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - sevelamer hydrochloride 400mg;   - film coated tablet - 400 mg - active: sevelamer hydrochloride 400mg   excipient: colloidal silicon dioxide purified water stearic acid

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - docetaxel 20 mg/ml - concentrate for infusion - 20 mg/ml - active: docetaxel 20 mg/ml excipient: ethanol polysorbate 80 - metastatic breast cancer taxotere is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. taxotere in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - docetaxel 40 mg/ml - concentrate for infusion - 40 mg/ml - active: docetaxel 40 mg/ml excipient: polysorbate 80 ethanol water for injection - metastatic breast cancer taxotere is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. taxotere in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - ibuprofen 200mg; paracetamol 500mg - film coated tablet - active: ibuprofen 200mg paracetamol 500mg excipient: croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry silver special effects 63f97546 opadry white 321a180025 pregelatinised maize starch purified talc purified water sodium laurilsulfate - temporary relief of acute pain and/or inflammation associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, period pain, sore throat, tennis elbow, rheumatic pain and arthritis and the aches and pains associated with colds and flu.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - ibuprofen 200mg; paracetamol 500mg - film coated tablet - active: ibuprofen 200mg paracetamol 500mg excipient: croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry silver special effects 63f97546 opadry white 321a180025 pregelatinised maize starch purified talc sodium laurilsulfate - temporary relief of acute pain and/or inflammation associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, period pain, sore throat, tennis elbow, rheumatic pain and arthritis and the aches and pains associated with colds and flu.

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - leflunomide 100mg - film coated tablet - 100 mg - active: leflunomide 100mg excipient: colloidal silicon dioxide crospovidone hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch povidone purified talc titanium dioxide - arava is indicated for the treatment of: · rheumatoid arthritis, to improve signs and symptoms to retard joint destruction and to improve functional ability and quality of life. leflunomide may be used in patients who have failed to respond to other treatments or as a first line of treatment in patients who have a contraindication to other treatments. · active psoriatic arthritis. arava is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - rifampicin 450mg - tablet - 450 mg - active: rifampicin 450mg